Unusual clinical presentation in a patient with myelodysplastic syndrome, with subsequent hematological remission and suppression of the malignant clone following treatment with cyclosporine A, erythropoietin and granulocyte colony-stimulating factor

Leuk Res. 1999 May;23(5):513-7. doi: 10.1016/s0145-2126(99)00038-7.

Abstract

A 35-year-old female presented with isolated thrombocytopenia of autoimmune origin. One and a half years later, hypoplastic myelodysplastic (MDS) was diagnosed. Following treatment with cyclosporin A, erythropoietin and granulocyte colony-stimulating factor, the patient has achieved a sustained hematological remission which is still ongoing after 3 years. Furthermore, to the best of our knowledge, this is the third case described in the literature where treatment with cytokines alone or in combination with immunosuppressive agents has resulted in a long standing cytogenetic response in MDS.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Autoimmune Diseases / drug therapy
  • Autoimmune Diseases / pathology
  • Cyclosporine / therapeutic use*
  • Disease Progression
  • Drug Therapy, Combination
  • Erythropoietin / therapeutic use*
  • Female
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • Humans
  • Myelodysplastic Syndromes / drug therapy*
  • Myelodysplastic Syndromes / pathology
  • Platelet Count / drug effects
  • Remission Induction / methods
  • Thrombocytopenia / drug therapy
  • Thrombocytopenia / pathology

Substances

  • Erythropoietin
  • Granulocyte Colony-Stimulating Factor
  • Cyclosporine